4.8 Article

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Infectious Diseases

SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

Ali Rostami et al.

Summary: The study revealed significant variations in SARS-CoV-2 seroprevalence among different geographic regions, possibly related to income levels, human development indices, geographic latitudes, and climates. It was estimated that approximately 263.5 million individuals had been exposed or infected globally by 2020.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Infectious Diseases

Genomic evidence for reinfection with SARS-CoV-2: a case study

Richard L. Tillett et al.

Summary: A man was infected with SARS-CoV-2 twice with genetically different virus variants, the second infection being more severe. The study suggests that previous exposure to SARS-CoV-2 may not guarantee immunity, and all individuals should take precautions to avoid infection. This has implications for vaccine development and application.

LANCET INFECTIOUS DISEASES (2021)

Letter Infectious Diseases

Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK

Julian W. Tang et al.

JOURNAL OF INFECTION (2021)

Article Medicine, General & Internal

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

S. F. Lumley et al.

Summary: In a longitudinal study of seropositive and seronegative health care workers undergoing asymptomatic and symptomatic SARS-CoV-2 testing, the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Article Infectious Diseases

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020

Anna Jeffery-Smith et al.

Summary: The study found that individuals who had prior exposure to SARS-CoV-2 had a significantly lower risk of re-infection after a second outbreak in two care homes in London. The protection offered by prior infection against re-infection was estimated to be around 96%, based on different statistical models.

EUROSURVEILLANCE (2021)

Review Public, Environmental & Occupational Health

Review Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis

P. Galanis et al.

Summary: The seroprevalence of SARS-CoV-2 antibodies among HCWs is relatively high and influenced by factors such as gender, race, work environment, and protective measures.

JOURNAL OF HOSPITAL INFECTION (2021)

Letter Infectious Diseases

Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK

Oliver T. R. Toovey et al.

JOURNAL OF INFECTION (2021)

Article Medicine, General & Internal

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

Raymond A. Harvey et al.

Summary: Understanding the impact of serum antibodies to SARS-CoV-2 on infection susceptibility is crucial for identifying at-risk populations and vaccine deployment. Results of the study suggest that individuals with positive antibody test results initially had a higher likelihood of positive NAAT results, but this likelihood decreased significantly over time, indicating that seropositivity may be associated with protection from infection, though the duration of this protection remains uncertain and may decrease over time.

JAMA INTERNAL MEDICINE (2021)

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Article Infectious Diseases

Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

Kasper Iversen et al.

LANCET INFECTIOUS DISEASES (2020)

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

Review Medicine, General & Internal

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Gregory A. Poland et al.

LANCET (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Ann-Sofie Rudberg et al.

NATURE COMMUNICATIONS (2020)

Article Immunology

MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015

Pyoeng Gyun Choe et al.

EMERGING INFECTIOUS DISEASES (2017)

Article Immunology

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

Daniel C. Payne et al.

EMERGING INFECTIOUS DISEASES (2016)

Review Public, Environmental & Occupational Health

The Danish Civil Registration System as a tool in epidemiology

Morten Schmidt et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)

Article Infectious Diseases

The Danish Microbiology Database (MiBa) 2010 to 2013

M. Voldstedlund et al.

EUROSURVEILLANCE (2014)

Article Immunology

Duration of antibody responses after severe acute respiratory syndrome

Li-Ping Wu et al.

EMERGING INFECTIOUS DISEASES (2007)

Letter Medicine, General & Internal

Disappearance of antibodies to SARS-associated coronavirus after recovery

Wu-Chun Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)